“Pharmaceutical executives who recently made a major donation to an anti-marijuana legalization campaign claimed they were doing so out of concern for the safety of children — but their investor filings reveal that pot poses a direct threat to their plans to cash in on a synthetic cannabis product they have developed.”
Related Posts
ContraReport Opioid/Cannabis 2016 Video Sources
- WOCredentials
- October 26, 2016
- 0
link to video: https://youtu.be/VY9udZKzUEg?si=LDZP6xTBsUkdBkN4 “78 Americans die every day from an opioid overdose.” – CDC ‘Understanding the Epidemic’ Since 2000 opioid overdose deaths have increased 200%. – Rudd, R. (2016). […]
Cannabinoids and the immune system: an overview (2010)
- WOCredentials
- June 16, 2016
- 0
“Cannabinoids can modulate immune reactions in the periphery but also in the brain, influence T cell subset balance and cytokine expression and play a role in the balance between neuroinflammation […]
Cannabinoids Decrease the Th17 Inflammatory Autoimmune Phenotype (2013)
- WOCredentials
- June 16, 2016
- 0
“Here we show that the main psychoactive cannabinoid, Δ-9-tetrahydrocannabinol (THC), and the main nonpsychoactive cannabinoid, cannabidiol (CBD), markedly reduce the Th17 phenotype which is known to be increased in inflammatory […]